Abstract:Venous thromboembolism (VTE) represents a worldwide health challenge, impacting millions of people each year. The genesis of venous thrombosis is influenced in part by genetic components. Hereditary thrombosis is described as a genetically determined susceptibility to VTE. In the present study, a male patient was referred to our department presenting with multiple venous thrombosis events in different locations. Given a lack of identifiable risk factors, we aimed to investigate the possible genetic factor underlying venous thrombosis. Whole-exome sequencing was employed to examine genes linked to inherited thrombophilia in the proband. Putative variants were subsequently confirmed through Sanger sequencing within the family. The proband was identified as carrying two genetic mutations. One is the novel c.400G > C (p.E134Q) mutation affecting the final nucleotide of exon 5 in the PROC gene, potentially impacting splicing. The other is a previously reported heterozygous nonsense variant c.1016G > A (p.W339X) in the SERPINC1 gene. The proband inherited the former from her mother and the latter from her father. The presence of digenic inheritance in the patient reflects the complex phenotype of venous thrombosis and demonstrates the significance of an unbiased approach to detect pathogenic variants, especially in patients with a high risk of hereditary thrombosis. Ethical approval was obtained from the Institutional Review Board, The Second Affiliated Hospital of Nanchang University. After explanation of the possible consequences of the study, written informed consent was obtained from all study participants. The patient provided informed consent for the publication of this study. All data generated or analyzed during this study are included in this published article Recruited and phenotyped the participants: X.G.L., W.W.Z. Performed molecular genetic experiments: X.G.L., W.W.Z. Analyzed the data: X.G.L., JBZ, W.W.Z. Wrote the manuscript: X.G.L., J.B.Z. Revised: F.Z.L., W.Q.M., W.M.Z. All authors read and approved the final manuscript. 1. Public single nucleotide polymorphism databases: dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP/); 1000G (http://www.1000genomes.org/); ESP(http://evs.gs.washington.edu/EVS); ExAC (http://exac.broadinstitute.org). Accessed September 15, 2022. 2. A toolkit that offers various utilities for working with high-throughput sequencing (HTS) data in the BAM format: Picard MarkDuplicates (http://sourceforge.net/projects/picard/). Accessed September 15, 2022. 3. Computational algorithms designed to predict the functional impact of amino acid substitutions on proteins: The PolyPhen2 (http://genetics.bwh.harvard.edu/pph2/) and SIFT (http://sift.bii.a-star.edu.sg/) algorithm. Accessed September 15, 2022. 4. The Human Gene Mutation Database (HGMD, http://www.hgmd.cf.ac.uk/ac/all.php). Accessed September 15, 2021. 5. A unique database focused on digenic diseases: The Digenic Diseases Database (DIDA: http://dida.ibsquare.be) database. Accessed September 15, 2022. 6. A computational tool designed to predict splice sites and splicing regulatory sequences in human genes: Human Splice Finder (HSF: https://hsf.genomnis.com/home). Accessed September 15, 2023. † X.L. and J.Z. should be considered joint first authors. Received: 19 June 2023 Accepted: 16 November 2023 Article published online: 15 January 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

A Novel Variation of SERPINC1 Caused Deep Venous Thrombosis in a Chinese Family: A Case Report.

Missense Mutation of SERPINC1 (p.ser426leu) in a Young Patient Presenting As Refractory and Recurrent Venous Thromboembolism: A Case Report.

Relationship Between Endothelial Cell Protein C Receptor Gene 6936A/G Polymorphisms and Deep Venous Thrombosis.

Atypical pulmonary thromboembolism caused by the mutation site SERPINC1 of the antithrombin III gene: A case report

A novel SERPINC1 c.119G>A (p.Cys40Tyr) mutation with variable clinical expression in an Indian family

Digenic Inheritance of PROC and SERPINC1 Mutations Contributes to Multiple Sites Venous Thrombosis

Inherited antithrombin deficiency caused by a mutation in the SERPINC1 gene: A case report

Clinical and functional characterization of rare compound heterozygous mutations in the SERPINC1 gene causing severe thrombophilia

Three case reports of inherited antithrombin deficiency in China: double novel missense mutations, a nonsense mutation and a frameshift mutation

Identification and characterization of two SERPINC1 mutations causing congenital antithrombin deficiency

The Association Between SERPINC1 C.883G>a and VT in the Chinese Population

SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency

A Small Deletion in SERPINC1 Causes Type I Antithrombin Deficiency by Promoting Endoplasmic Reticulum Stress

Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency

Inherited Antithrombin III Deficiency: A Case Report of Familial Pedigree and Gene Mutation Screening

Case Report: PROS1 (c.76+2_76+3del) pathogenic mutation causes pulmonary embolism

Rare Double Heterozygous Mutations in Antithrombin Underlie Hereditary Thrombophilia in a Chinese Family.

Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation

A Novel Splicing Mutation in the PROS1 Gene Causes Hereditary Protein S Deficiency in a Chinese Family with Thrombotic Disease.

Molecular Basis and Thrombotic Manifestations of Antithrombin Deficiency in 15 Unrelated Chinese Patients.

Prothrombin Arg541Trp Mutation Leads to Defective PC (Protein C) Pathway Activation and Constitutes a Novel Genetic Risk Factor for Venous Thrombosis